Drug Shortage Report for INTEGRILIN

Last updated on 2018-07-04 History
Report ID 51168
Drug Identification Number 02240352
Brand name INTEGRILIN
Common or Proper name Eptifibatide Injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) EPTIFIBATIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20MG/10ML BOLUS VIAL
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-06-04
Actual start date 2018-06-04
Estimated end date 2018-07-06
Actual end date 2018-07-03
Shortage status Resolved
Updated date 2018-07-04
Company comments limited quantity available
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-07-04 English Compare
v5 2018-07-03 French Compare
v4 2018-07-03 English Compare
v3 2018-06-05 English Compare
v2 2018-06-04 French Compare
v1 2018-06-04 English Compare